Soluble human complement receptor type 1 inhibits complement-mediated host defense.

Soluble complement receptor type 1 (sCR1) is a powerful inhibitor of complement activation. Because of this ability, sCR1 may prove to be an important therapeutic agent that can be used to block the immunopathologic effects of uncontrolled complement activation in a variety of clinically significant...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	Clin Diagn Lab Immunol
Egile Nagusiak:	Swift, A J, Collins, T S, Bugelski, P, Winkelstein, J A
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 1994
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC368344/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8556505/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/cdli.1.5.585-589.1994
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!